Sales tax classification of Boroline turned on commercial identity and notification language, not a drug licence alone.

Boroline was classified as a cosmetic under the 1975 sales tax notification because the commodity had to be identified by the language of the relevant notification, its commercial character and common trade use, not by isolated medicinal ingredients. The 1956 notification's cross-reference to the Drugs and Cosmetics Act did not override the separate wording of the later notification, which expressly covered creams. A drug manufacturing licence under the Drugs and Cosmetics Act was held not conclusive for sales tax classification; it was only one piece of evidence and the taxing authority had to decide the commodity's character independently.

---

---

Issues: (i) Whether Boroline fell within the notified category of "drug" or "patent or proprietary medicine" under the 1956 notification made under section 25 of the West Bengal Sales Tax Act, 1954, or was a "cosmetic" under the 1975 notification; (ii) whether the existence of a drug manufacturing licence under the Drugs and Cosmetics Act, 1940, was conclusive for sales tax classification.

Issue (i): Whether Boroline fell within the notified category of "drug" or "patent or proprietary medicine" under the 1956 notification made under section 25 of the West Bengal Sales Tax Act, 1954, or was a "cosmetic" under the 1975 notification.

Analysis: The notifications were construed according to their own language. The 1956 notification adopted the definitions of "drug" and "patent or proprietary medicine" from the Drugs and Cosmetics Act, 1940, while the 1975 notification used the expression "cosmetics of all varieties" and specifically included creams. On the evidence, Boroline was a cream used in common parlance as a cosmetic preparation and its composition did not justify treating the whole preparation as a drug or a patent or proprietary medicine. The Court held that a preparation is to be classified by its own legal description and use in trade, not by isolated medicinal ingredients or by references to other proceedings under different statutes.

Conclusion: Boroline was held to be a cosmetic and not a drug or patent or proprietary medicine; the conclusion was against the assessee and in favour of Revenue.

Issue (ii): Whether the existence of a drug manufacturing licence under the Drugs and Cosmetics Act, 1940, was conclusive for sales tax classification.

Analysis: The licensing provisions under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945, were examined. The Court held that the grant or renewal of a drug licence is not a conclusive determination for sales tax purposes because the licensing process does not finally adjudicate the tax classification of the preparation. The taxing authority must independently decide the character of the commodity under the sales tax notifications, though the licence may be considered as one piece of evidence.

Conclusion: The drug licence was held not to be conclusive evidence that Boroline was a drug for sales tax purposes; the conclusion was against the assessee and in favour of Revenue.

Final Conclusion: The impugned revisional order was set aside and the earlier appellate classification treating Boroline as a taxable cosmetic was restored.

Ratio Decidendi: Where a sales tax notification defines goods by reference to another statute for one class of goods but uses an independent expression for another, classification must be made on the language of the relevant notification and the commercial identity of the commodity, and a manufacturing licence under a different regulatory law does not conclusively determine tax classification.

---